bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods necessary to find lung cancer at its earliest stages.
read moreBioAffinity Technologies is proud to be named a finalist in the Lyfebulb Helsinn 2019 Innovation Summit in Oncology, March 18 and 19, 2019 in Monaco.
read morebioAffinity Technologies' CEO, Maria Zannes, will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
read morebioAffinity Technologies' CEO, Maria Zannes, will lead a panel of leaders from UT Health, UTSA and the City of San Antonio to discuss how the Company has grown in San Antonio and how others can benefit from their story. Thursday, November 9 at noon at the San Antonio Airport Hilton.
read moreOnline registration is now open and the RSVP deadline is Fri. May 19th. ACG Member price: $30./Non-ACG Member price: $55. until the RSVP deadline.
read more
bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.